Trente-six cas français de lymphomes anaplasiques à grandes cellules associés aux implants mammaires. Que savons-nous sur leur histoire prothétique ?

Ruffenach, L.; Bruant-Rodier, C.; Goldammer, F.; Ramelli, E; Bodin, F.; Dissaux, C.

doi:10.1016/j.anplas.2019.05.002

Cited by 11 publications

(2 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…23 Tribology (ie, friction, wear), subclinical infection, and an atypical immune response to silicone have been proposed as direct mechanisms. Late seroma is the most common manifestation, presenting in 60% to 90% of cases after several years, 24 although development of a mass (10% to 40%), lymphadenopathy, and capsular contracture have also been reported. 25,26 Surgical treatment is the optimal approach, with removal of the implant and total capsulectomy; additional lymphadenectomy is highly recommended for advanced stages (II through IV).…”

Section: Discussionmentioning

confidence: 99%

Abdominoplasty and Breast Augmentation with Outpatient Cosmetic Deep Inferior Epigastric Perforator Flaps

Martínez

Boutros

2022

Plastic &Amp; Reconstructive Surgery

View full text Add to dashboard Cite

Breast augmentation became the most common cosmetic surgical procedure in 2019, with more than 280,000 operations performed in the United States. 1 Breast augmentation with implants is a relatively inexpensive and straightforward low-risk procedure that yields good results. Early potential problems are well-known; later complications, such as rupture, long-term deflation, malposition, pain, and capsular contraction, typically require surgical correction. Significant long-term complications, such as breast implant-associated anaplastic large cell lymphoma 2 and breast implant illness, 3 occur in Background: The authors describe the use of deep inferior epigastric perforator (DIEP) flaps in outpatient cosmetic breast augmentation. Methods: The authors reviewed patients who had undergone cosmetic breast augmentation with DIEP flaps over a 12-month period. Any patient who desired breast augmentation, implant exchange, or augmentation mastopexy with concomitant abdominoplasty was considered a candidate for the procedure. All patients underwent an early recovery protocol including microfascial incisions to harvest the DIEP flaps and rib preservation in addition to early recovery after surgery protocols with intraoperative anesthetic blocks. Results: Eleven consecutive patients underwent bilateral cosmetic breast augmentation with DIEP flaps and mastopexy. Overall, all patients reported preoperative dissatisfaction with their abdomen and breasts. Microfascial incisions for single perforator abdominal flaps (n = 17) averaged 1.7 cm (range, 1.3 to 2.4 cm) and flaps with multiple perforators (n = 5) averaged 2.4 cm (range, 2 to 2.5 cm). Dissection of recipient internal mammary artery vessels was performed without disruption of the rib. No fascia or muscle tissue was taken during flap dissection. All patients had strong Doppler signals before discharge within 23 hours. No partial or total flap losses, major complications, or take-backs were reported. Conclusions: Patients who desire abdominoplasty and augmentation are ideal candidates for this procedure. Breast augmentation with autologous tissue, particularly the DIEP flap, is an attractive option inherent to the additional abdominal tissue available to harvest. The early recovery protocol allows the surgeon to perform microsurgical breast reconstructions and augmentations in an outpatient setting, with excellent results and no total or partial flap losses, offsetting the high costs associated with the DIEP flap.

show abstract

Section: Discussionmentioning

confidence: 99%

Abdominoplasty and Breast Augmentation with Outpatient Cosmetic Deep Inferior Epigastric Perforator Flaps

Martínez

Boutros

2022

Plastic &Amp; Reconstructive Surgery

View full text Add to dashboard Cite

show abstract

“…In conclusion, the current study displays a notable variation in the number of confirmed BIA-ALCL cases. Variations in diagnosis and reporting systems may explain the differences, but the influence of genetic variations and the prevalence of high-risk implants cannot be excluded [17]. Incomplete sales data, together with medical tourism, preclude an absolute risk assessment.…”

Section: Discussionmentioning

confidence: 99%

Considerations on the Demography of BIA-ALCL in European Countries Based on an E(A)SAPS Survey

Stark

Magnéli

Heijningen³

et al. 2021

Aesth Plast Surg

View full text Add to dashboard Cite

Background A growing body of evidence indicates that breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is associated with the use of certain breast implants. Regional variations have been reported, and a genetic susceptibility has also been suggested. However, large variations in the ability to correctly diagnose BIA-ALCL and to further report and register cases exist between countries and may in part explain variations in the demography. Material and Methods A survey was conducted by The European Association of Societies of Aesthetic Plastic Surgery E(A)SAPS and sent to 48 European countries. The primary aim was to identify the total number of confirmed cases of and deaths from BIA-ALCL in each country during four consecutive measurements over a two-year period. Results An increase in BIA-ALCL cases during four repeated measurements from a total of 305 in April 2019 to 434 in November 2020 was reported by 23 of the 33 responding countries. A nearly 100-fold variation in the number of cases per million inhabitants was noted, where Netherlands had the highest rate (4.12) followed by Finland (1.99). Countries with the lowest reported rates were Austria (0.078), Romania (0.052) and Turkey (0.048). Conclusion The current study displays a notable variation ßin the number of confirmed BIA-ALCL cases across Europe, even for countries with established breast implant registers. Variations in diagnosis and reporting systems may explain the differences, but the influence of genetic variations and the prevalence of high-risk implants cannot be excluded. Incomplete sales data along with medical tourism preclude an absolute risk assessment. Level of Evidence IV This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.

show abstract

Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) and the Textured Breast Implant Crisis

Groth

Graf

2019

Aesth Plast Surg

View full text Add to dashboard Cite

Trente-six cas français de lymphomes anaplasiques à grandes cellules associés aux implants mammaires. Que savons-nous sur leur histoire prothétique ?

Cited by 11 publications

References 17 publications

Abdominoplasty and Breast Augmentation with Outpatient Cosmetic Deep Inferior Epigastric Perforator Flaps

Abdominoplasty and Breast Augmentation with Outpatient Cosmetic Deep Inferior Epigastric Perforator Flaps

Considerations on the Demography of BIA-ALCL in European Countries Based on an E(A)SAPS Survey

Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) and the Textured Breast Implant Crisis

Contact Info

Product

Resources

About